{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:16:31Z","timestamp":1788113791145,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species and\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      are environmental gram-negative bacteria that are rarely implicated in chronic suppurative otitis media (CSOM).\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species are emerging opportunistic pathogens, primarily associated with respiratory infections in immunocompromised individuals, while\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      is typically associated with seafood-related gastroenteritis. This case highlights the co-isolation of\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species and\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      from a patient with CSOM who frequently engaged in sea swimming, suggesting their potential role in CSOM pathogenesis and a possible environmental source of infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 15-year-old male, a sea swimmer, presented with persistent otorrhea and hearing impairment despite multiple courses of antibiotics. Otoscopic examination revealed tympanic membrane perforation with purulent discharge. Microbiological culture of the ear discharge isolated\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species and\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      , confirmed by matrix-assisted laser desorption\/ionization time of flight-mass spectrometry (MALDI-TOF MS).\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species exhibited multidrug resistance, with susceptibility only to carbapenems, whereas\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      was susceptible to fluoroquinolones and tetracyclines. Targeted antimicrobial therapy led to clinical improvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This case underscores the need to consider\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species and\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      as potential pathogens in non-resolving CSOM cases, especially in individuals exposed to marine environments. Their multidrug-resistance patterns highlight the importance of culture-based diagnosis and susceptibility testing for effective management. Further studies are needed to explore the epidemiology and clinical significance of\n                      <jats:italic>Achromobacter<\/jats:italic>\n                      species and\n                      <jats:italic>Vibrio parahaemolyticus<\/jats:italic>\n                      in ear infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12329-9","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T06:26:22Z","timestamp":1766816782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Co-isolation of Achromobacter species and Vibrio parahaemolyticus from a case of chronic suppurative otitis media in a sea swimmer: a case report"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-5134","authenticated-orcid":false,"given":"Engy","family":"Aboelsaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"El-Badan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila El","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"12329_CR1","unstructured":"Abdullah M. Endoscopic assessment of the tympanic isthmus and tensor tympani fold as ventilation routes in cases of chronic suppurative otitis media. Faculty of Medicine, Alexandria University; 2018."},{"key":"12329_CR2","doi-asserted-by":"crossref","unstructured":"Monasta L, Ronfani L, Marchetti F, Montico M, Brumatti L, Bavcar A, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS ONE. 2012;7.","DOI":"10.1371\/journal.pone.0036226"},{"issue":"4","key":"12329_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/1947-2714.110436","volume":"5","author":"R Prakash","year":"2013","unstructured":"Prakash R, Juyal D, Negi V, Pal S, Adekhandi S, Sharma M, et al. Microbiology of chronic suppurative otitis media in a tertiary care setup of Uttarakhand State, India. N Am J Med Sci. 2013;5(4):282\u20137.","journal-title":"N Am J Med Sci"},{"issue":"1","key":"12329_CR4","first-page":"1","volume":"3","author":"IA Abdelshafy","year":"2015","unstructured":"Abdelshafy IA, Haleem AA, Khalil YA, Ghazal AA, Gaballah A, Saied A. Microbiology of chronic suppurative otitis Media,Study of the role of bacterial biofilm and fungal infection. J Otolaryngol Res. 2015;3(1):1\u20136.","journal-title":"J Otolaryngol Res"},{"issue":"1","key":"12329_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1017\/S0022215115002509","volume":"130","author":"AS Harris","year":"2016","unstructured":"Harris AS, Elhassan HA, Flook EP. Why are ototopical aminoglycosides still first-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones. J Laryngol Otol. 2016;130(1):2\u20137.","journal-title":"J Laryngol Otol"},{"issue":"5","key":"12329_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/00016489.2025.2471940","volume":"145","author":"A Wang","year":"2025","unstructured":"Wang A, et al. Evaluation of surgical intervention for chronic suppurative otitis media in patients with hematologic diseases. Acta Otolaryngol. 2025;145(5):390\u20134.","journal-title":"Acta Otolaryngol"},{"key":"12329_CR7","volume-title":"Chronic suppurative otitis media: burden of illness and management options","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Chronic suppurative otitis media: burden of illness and management options. Geneva: World Health Organization; 2004."},{"issue":"2","key":"12329_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejenta.2014.03.002","volume":"15","author":"AA Elmanama","year":"2014","unstructured":"Elmanama AA, Tayyem NEA, Allah SAN. The bacterial etiology of otitis media and their antibiogram among children in Gaza Strip, Palestine. Egypt J Ear Nose Throat Allied Sci. 2014;15(2):87\u201391.","journal-title":"Egypt J Ear Nose Throat Allied Sci"},{"issue":"2","key":"12329_CR9","doi-asserted-by":"publisher","first-page":"e01287","DOI":"10.1002\/rcr2.1287","volume":"12","author":"T Kotani","year":"2024","unstructured":"Kotani T, Inazaki T, Kasai H, Rakuman S, Suzuki K, Urushibara T. Pneumonia due to achromobacter xylosoxidans with a chronic course resembling non-tuberculous mycobacterial infection. Respirol Case Rep. 2024;12(2):e01287.","journal-title":"Respirol Case Rep"},{"issue":"11","key":"12329_CR10","doi-asserted-by":"publisher","first-page":"e01025","DOI":"10.1128\/AAC.01025-20","volume":"64","author":"B Isler","year":"2020","unstructured":"Isler B, Kidd TJ, Stewart AG, Harris P, Paterson DL. Achromobacter infections and treatment options. Antimicrob Agents Chemother. 2020;64(11):e01025\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"12329_CR11","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/jcm14072437","volume":"14","author":"O Bar-On","year":"2025","unstructured":"Bar-On O, Mei-Zahav M, Levine H, Mussaffi H, Blau H, Ben Zvi H, et al. The association of Achromobacter xylosoxidans airway infection with disease severity in cystic fibrosis. J Clin Med. 2025;14(7):2437.","journal-title":"J Clin Med"},{"key":"12329_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fcimb.2013.00097","volume":"3","author":"D Ceccarelli","year":"2013","unstructured":"Ceccarelli D, Hasan NA, Huq A, Colwell RR. Distribution and dynamics of epidemic and pandemic vibrio parahaemolyticus virulence factors. Front Cell Infect Microbiol. 2013;3:97.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"12329_CR13","first-page":"362","volume":"12","author":"OA Afolabi","year":"2012","unstructured":"Afolabi OA, Salaudeen AG, Ologe FE, Nwabuisi C, Nwawolo CC. Pattern of bacterial isolates in the middle ear discharge of patients with chronic suppurative otitis media in a tertiary hospital in North central Nigeria. Afr Health Sci. 2012;12(3):362\u20138.","journal-title":"Afr Health Sci"},{"key":"12329_CR14","volume-title":"Bailey and scott\u2019s diagnostic microbiology","author":"B Forbes","year":"2017","unstructured":"Forbes B, Sahm D, Weissfeld A. Bailey and scott\u2019s diagnostic microbiology. 14th ed. St. Louis: Mosby Inc; 2017.","edition":"14"},{"key":"12329_CR15","first-page":"772","volume-title":"Medical mycology","author":"J Rippon","year":"1982","unstructured":"Rippon J. Medical mycology. 2nd ed. Canada: Saunders company; 1982. pp. 772\u201395.","edition":"2"},{"key":"12329_CR16","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 34th ed. Suppl M100 CLSI; 2024."},{"issue":"5","key":"12329_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1348-0421.1971.tb00607.x","volume":"15","author":"E Yabuuchi","year":"1971","unstructured":"Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol. 1971;15(5):477\u201381.","journal-title":"Jpn J Microbiol"},{"key":"12329_CR18","doi-asserted-by":"crossref","unstructured":"Cheong RC, Harding L. Septic arthritis of the temporomandibular joint secondary to acute otitis media in an adult: a rare case with Achromobacter xylosoxidans. Case rep Otolaryngol. 2017;2017.","DOI":"10.1155\/2017\/3641642"},{"key":"12329_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.xocr.2018.03.003","volume":"7","author":"E Ikari","year":"2018","unstructured":"Ikari E, Komune N, Nakagawa T. Chronic mastoiditis and petrositis with viscous otorrhea caused by achromobacter xylosoxidans: case report and literature review. Otolaryngol Case Rep. 2018;7:3\u20136.","journal-title":"Otolaryngol Case Rep"},{"issue":"6","key":"12329_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jac\/26.6.857","volume":"26","author":"KV Rolston","year":"1990","unstructured":"Rolston KV, Messer M. The in-vitro susceptibility of alcatigenes deni-trificans subsp. Xylosoxidans to40 anti-microbial agents. J Antimicrob Chemother. 1990;26(6):857\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"12329_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0005-8","volume":"4","author":"C Baker-Austin","year":"2018","unstructured":"Baker-Austin C, Oliver JD, Alam M, Ali A, Waldor MK, Qadri F, Martinez-Urtaza J. Vibrio spp. Infections. Nat Reviews Disease Primers. 2018;4(1):1\u20139.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"12329_CR22","first-page":"1","volume":"11","author":"S Ngasotter","year":"2022","unstructured":"Ngasotter S, Mukherjee S, Singh SK, Bharti D, Haque R, Varshney S, Nanda C, Waikhom D, Devi MS, Singh AS. Prevalence, Virulence, and antibiotic resistance of vibrio parahaemolyticus from seafood and its environment: an updated review. Mediterr J Infect Microb Antimicrob. 2022;11(1):1\u20131.","journal-title":"Mediterr J Infect Microb Antimicrob"},{"key":"12329_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3389\/fmicb.2016.02146","volume":"7","author":"AP Magalh\u00e3es","year":"2017","unstructured":"Magalh\u00e3es AP, Lopes SP, Pereira MO. Insights into cystic fibrosis polymicrobial consortia: the role of species interactions in biofilm development, phenotype, and response to in-use antibiotics. Front Microbiol. 2017;7:2146.","journal-title":"Front Microbiol"},{"issue":"8","key":"12329_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/pathogens10080978","volume":"10","author":"A Sandri","year":"2021","unstructured":"Sandri A, Haagensen JAJ, Veschetti L, Johansen HK, Molin S, Malerba G, Signoretto C, Boaretti M, Lleo MM. Adaptive interactions of Achromobacter spp. With Pseudomonas aeruginosa in cystic fibrosis chronic lung Co-Infection. Pathogens. 2021;10(8):978.","journal-title":"Pathogens"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12329-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:22:51Z","timestamp":1769516571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12329"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12329-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study follows the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee at the High Institute of Public Health, Alexandria University, Egypt. Informed consent was obtained from the patient. All methods were performed in accordance with the relevant guidelines and regulations for ethics approval and consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for his personal and clinical details to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}